Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter J. Graham currently holds 359,034 shares of ANTARES PHARMA, INC. (ATRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter J. Graham has been a net seller of ATRS stock. They have purchased $15.4K and sold $221.7K worth of shares.
Peter J. Graham's most recent insider trade was on Dec 6, 2025, when they sold 49,508 shares at $3.29 per share.
Peter J. Graham serves as Executive at ANTARES PHARMA, INC. (ATRS). They have executed 49 insider transactions totaling $237.1K over their tenure at the company.
Peter J. Graham holds the position of Executive at ANTARES PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Peter J. Graham has shown a selling trading pattern, with $15.4K in total purchases and $221.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter J. Graham was on May 24, 2022, when they sold $2.3M worth of ATRS shares. This transaction involved 414,470 shares at $5.60 per share.
Peter J. Graham currently owns 359,034 shares of ANTARES PHARMA, INC. (ATRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter J. Graham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter J. Graham has 49 Form 4 filings on record as an insider at ANTARES PHARMA, INC..
Set alerts for Peter J. Graham and 40,000+ other insiders.